Free Trial

Tenet Healthcare (NYSE:THC) Shares Gap Up - Still a Buy?

Tenet Healthcare logo with Medical background

Tenet Healthcare Co. (NYSE:THC - Get Free Report) shares gapped up prior to trading on Tuesday . The stock had previously closed at $139.49, but opened at $147.70. Tenet Healthcare shares last traded at $151.39, with a volume of 352,613 shares trading hands.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Wells Fargo & Company increased their target price on Tenet Healthcare from $175.00 to $195.00 and gave the company an "overweight" rating in a research note on Tuesday, October 22nd. Citigroup raised their price objective on Tenet Healthcare from $139.00 to $171.00 and gave the company a "buy" rating in a research note on Thursday, July 25th. Raymond James raised their price objective on Tenet Healthcare from $130.00 to $175.00 and gave the company a "strong-buy" rating in a research note on Thursday, July 25th. UBS Group boosted their target price on Tenet Healthcare from $180.00 to $197.00 and gave the stock a "buy" rating in a report on Wednesday, August 14th. Finally, KeyCorp started coverage on Tenet Healthcare in a research report on Friday, October 11th. They issued an "overweight" rating and a $200.00 price target for the company. One analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and four have issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and a consensus price target of $157.24.

Get Our Latest Stock Report on Tenet Healthcare

Tenet Healthcare Price Performance

The firm has a fifty day simple moving average of $159.51 and a 200 day simple moving average of $141.04. The company has a market capitalization of $15.60 billion, a PE ratio of 5.53, a P/E/G ratio of 0.71 and a beta of 2.14. The company has a debt-to-equity ratio of 2.53, a quick ratio of 1.38 and a current ratio of 1.45.

Tenet Healthcare declared that its board has approved a stock repurchase program on Wednesday, July 24th that permits the company to buyback $1.50 billion in outstanding shares. This buyback authorization permits the company to purchase up to 10.3% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's leadership believes its stock is undervalued.

Insiders Place Their Bets

In other Tenet Healthcare news, insider R. Scott Ramsey sold 11,599 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $162.06, for a total transaction of $1,879,733.94. Following the sale, the insider now owns 6,324 shares of the company's stock, valued at approximately $1,024,867.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Tenet Healthcare news, insider R. Scott Ramsey sold 11,599 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $162.06, for a total transaction of $1,879,733.94. Following the sale, the insider now owns 6,324 shares of the company's stock, valued at approximately $1,024,867.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Meghan Fitzgerald sold 20,000 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $146.34, for a total value of $2,926,800.00. Following the sale, the director now directly owns 15,269 shares in the company, valued at $2,234,465.46. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 128,203 shares of company stock worth $19,754,997 in the last ninety days. 0.93% of the stock is owned by company insiders.

Institutional Trading of Tenet Healthcare

A number of institutional investors have recently made changes to their positions in THC. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Tenet Healthcare by 0.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,604 shares of the company's stock valued at $1,325,000 after buying an additional 90 shares during the last quarter. Optas LLC raised its stake in shares of Tenet Healthcare by 3.4% during the 3rd quarter. Optas LLC now owns 2,821 shares of the company's stock valued at $469,000 after buying an additional 93 shares during the last quarter. Signaturefd LLC raised its stake in shares of Tenet Healthcare by 17.6% during the 3rd quarter. Signaturefd LLC now owns 628 shares of the company's stock valued at $104,000 after buying an additional 94 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Tenet Healthcare by 20.7% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 560 shares of the company's stock valued at $74,000 after buying an additional 96 shares during the last quarter. Finally, First Citizens Bank & Trust Co. raised its stake in shares of Tenet Healthcare by 5.1% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 2,226 shares of the company's stock valued at $370,000 after buying an additional 109 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.

About Tenet Healthcare

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

See Also

→ Algo Trading Is Here 🔥 (From Timothy Sykes) (Ad)

Should you invest $1,000 in Tenet Healthcare right now?

Before you consider Tenet Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.

While Tenet Healthcare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Post-Election Chaos or Opportunity? Prepare Your Investments
Strong Markets Meet Rising Volatility—Are Your Investments Safe?
Analysts Bullish on AI-Powered Healthcare: Intuitive Surgical’s 30% Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines